Established
2009

Attendees
11,500

Speakers
1,700

Companies
2,050

Conference Co-Hosts

“As Precision Medicine is evolving rapidly, it is important to have a forum that fosters the discussion and collaboration among stakeholders across the research, medical, and pharma communities to be able to deliver cutting-edge care and clinical trial opportunities.

PMWC 2018 SV is a critical component in this context. I am grateful for the opportunity to help shape the focus and structure of the next PMWC conference to advance precision medicine towards its ultimate goal of becoming a true reality for all cancer patients.”

George Sledge, JR., M.D., PMWC 2018 Silicon Valley Program Chair

Professor, Division Chief, Stanford University Medical Center

Program

Topics Include:

AI & Machine Learning, All of Us Research Program, Big data, Biomarker and companion diagnostics, Cancer and rare disease diagnostics, Clinical NGS, Clinical trial developments, Clinical-decision support, CRISPR, Data and regulatory policies, Digital, mHealth, and Telehealth, Drug discovery, PM Economics and socio-political aspects, Immunotherapy, Infectious disease ID and monitoring, Large scale human genetics, Liquid biopsy, Metabolomics, Overcoming data sharing, PM initiatives, Microbiome, Patient engagement, Valued-based healthcare, Wellness & Aging

Session List:

CRISPR Technology – How It Has Changed Biological Research

Session Chair: Emmanuelle Charpentier, Max Planck Institute

Making RNA Analysis Routine in the Clinic

Session Chair: Rebecca Brandes, Agilent

AI-driven Pre-clinical and Clinical Drug Design, Discovery, and Development

Session Chair: Alex Zhavoronkov, Insilico Medicine, Inc

Targeting the Tumor Microenvironment

Session Chair: Jennifer A. Wargo, MD Anderson

CRISPR Technology – How It Has Changed Biological Research

Session Chair: Emmanuelle Charpentier, Max Planck Institute

Making RNA Analysis Routine in the Clinic

Session Chair: Rebecca Brandes, Agilent

Bringing the Next Generation of IO Biomarkers to the Clinic

Session Chair: Alessandra Cesano, Nanostring

AI-driven Pre-clinical and Clinical Drug Design, Discovery, and Development

Session Chair: Alex Zhavoronkov, Insilico Medicine, Inc

Economic and Socio-political Aspects of Precision Medicine

Session Chair: Kevin Knopf, Cancer Commons

Targeting the Tumor Microenvironment

Session Chair: Jennifer A. Wargo, MD Anderson

See All Sessions

Testimonials

See PMWC talk & session videos

“PMWC has proven, time and time again, that it attracts thought-leaders from all the relevant fields and catalyzes crucial collaboration through inspiring and practical program content. This is the Conference for entrepreneurs to meet payors, and for researchers to connect with service providers and for clinicians to hear from leading providers.”

Lee Hood, PhD, MD

President, Institute for Systems Biology

“PMWC provides a valuable insight for physicians and others who may be wondering how close we are getting to realizing the arrival of personalized medicine. The conferences are helpful in understanding where and how the envelope is being pushed.”

Peter Paul Yu, MD, FACP, FASCO

Immediate Past President, ASCO

“PMWC is a very well organized conference based in Silicon Valley that addresses all of the salient issues facing personalized medicine and offers emerging personalized medicine companies a chance to showcase their latest innovations, reminding us how exciting the field is.”

Ed Abrahams, PhD

President, PMC

Get Updates

Conference Co-Hosts

Program

CRISPR Technology – How It Has Changed Biological Research

Session Chair: Emmanuelle Charpentier, Max Planck Institute

Making RNA Analysis Routine in the Clinic

Session Chair: Rebecca Brandes, Agilent

AI-driven Pre-clinical and Clinical Drug Design, Discovery, and Development

Session Chair: Alex Zhavoronkov, Insilico Medicine, Inc

Targeting the Tumor Microenvironment

Session Chair: Jennifer A. Wargo, MD Anderson

CRISPR Technology – How It Has Changed Biological Research

Session Chair: Emmanuelle Charpentier, Max Planck Institute

Making RNA Analysis Routine in the Clinic

Session Chair: Rebecca Brandes, Agilent

Bringing the Next Generation of IO Biomarkers to the Clinic

Session Chair: Alessandra Cesano, Nanostring

AI-driven Pre-clinical and Clinical Drug Design, Discovery, and Development

Session Chair: Alex Zhavoronkov, Insilico Medicine, Inc

Economic and Socio-political Aspects of Precision Medicine

Session Chair: Kevin Knopf, Cancer Commons

Targeting the Tumor Microenvironment

Session Chair: Jennifer A. Wargo, MD Anderson

Speakers

Alan Ashworth
UCSF

Aris Baras
Regeneron Genetics Center

Sir John Bell
Oxford University

Emmanuelle Charpentier
Max Planck Institute

Vinod Khosla
Khosla Ventures

Ronald Levy
Stanford University

Ira Mellman
Genentech

George Sledge
Stanford University

Alan Ashworth
UCSF

Sir John Bell
Oxford University

Emmanuelle Charpentier
Max Planck Institute

Vinod Khosla
Khosla Ventures

Ronald Levy
Stanford University

Ira Mellman
Genentech

Testimonials

Don't Miss Important Precision Medicine Updates

View the top 3 talks from PMWC here (password: top-videos).